Related Experiment Video

Updated: Apr 18, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K

Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling

Pouyan Ghaffari1, Adil Mardinoglu1, Anna Asplund2

  • 1Department of Biology and Biological Engineering, Chalmers University of Technology, SE-412 96, Gothenburg, Sweden.

Scientific Reports
|February 3, 2015
PubMed

Insights

Researchers developed personalized cancer metabolic models to identify novel anti-cancer drugs. They discovered 85 potential antimetabolites, with 60 effective against all tested cancer cell lines and safe for healthy cells, paving the way for new cancer therapies.

Area of Science:

  • Computational biology and cancer research.
  • Metabolic modeling and drug discovery.

Background:

  • Human cancer cell lines are crucial models for understanding tumor growth and heterogeneity.
  • Genomic and biological variations in tumors influence cellular behavior and drug response.

Purpose of the Study:

  • To reconstruct and validate genome-scale metabolic models (GEMs) for eleven cancer cell lines.
  • To analyze metabolic differences and explore metabolic subsystem heterogeneity across cell lines.
  • To predict novel antimetabolites for cancer treatment with minimal toxicity to healthy cells.

Main Methods:

  • Reconstruction of GEMs using RNA-Seq data for eleven human cancer cell lines.
  • Validation of GEM functionality using metabolite profiling data.
  • In silico prediction of antimetabolites targeting cancer cell growth.
  • Experimental validation of a predicted antimetabolite.
  • Immunohistochemistry to assess target protein expression.

Main Results:

  • GEMs were reconstructed and validated for eleven cancer cell lines.
  • 85 potential antimetabolites were predicted, with 60 effective against all cell lines and non-toxic to healthy cells.
  • Experimental validation confirmed the efficacy of one predicted antimetabolite in inhibiting cancer cell growth.
  • High or moderate expression of target proteins was observed in cancer cells.

Conclusions:

  • Personalized metabolic models can reveal cancer cell-specific metabolic vulnerabilities.
  • Predicted antimetabolites offer promising leads for developing targeted cancer therapies.
  • The study provides a framework for identifying novel anti-cancer agents with improved safety profiles.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K
A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

9.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.8K